Table 2

Individual PAH patient characteristics, including medication.

Age (yrs)Weight (kg)BMI (kg/m2)WHO ClassMedication*
Diagnosis†: IPAH
635926.21SIL, TREPIN, VAL, O2
317028.41AMB, SIL, TREPIN, DIG, O2
336422.71NIF, WAR
3357201SIL, WAR, PPI
339128,11THY, PRE, TREPIV, O2, intravenous immunoglobuline, IRO, WAR, VEN, AMI, SPI, LIS, TOR, BOS, PPI, TRAM, PRC
495921,71BOS, FUR, NIF, WAR, SAL, SER
409434,51AMB, AML, FUR, TAD
265819,41AML, FUR, SIL, WAR
415920.92BOS, SIL, NIF, WAR
504919.92BOS, TAD, ASA, SIM, SER
477028.42BOS, TREPIV, HCT, WAR, ESC, GAB
195421.92SIL, TREPIV, FUR, ALD, DIG, WAR, IRO, PPI
748429.82SIL, THY, WAR, SD, CEL
5010236.12BOS, SIL, FUR, ALD, WAR, FLU, FEX, PPI
607531.22AMB, TRI, ALD, NAP
446123.82EPIV, ALD, FLU, BUP, GAB
387826.12BOS, TAD, TREPIV, FUR
498630.52AMB, AML, TREPIN, TOR, HCT, PRA, PPI, O2
316822.22PGI, WAR, ESC, GAB, PPI
345122.72BOS, SIL, TREPSC, FUR, DIG, IRO, HYD, PRE
4868252AMB, TAD, TREPPO, CAV, WAR, BUM, RIS, PPI, TRAM, HYD, Calcium, CET, TEM, TRA, ALP
4388352BOS, SIL, SPI, FUR, ATO, WAR, ILO
685319,52NIF, WAR, SIM, FLU, PPI, ASA, ALP, IRO, PRC, COD, RAN
527127,42BOS, TAD, SPI, FUR, MEF, SIT, LIS, DIG, CLG, DUL, LOV, THY, KCL, FAM
3710933,62TAD, AMB, WAR, CET, RAN, SER, GUA, FLT
486624,82TREPIN, BOS, DIG, TAD, DIL
2161232SIL, AMB, WAR, DIG, PPI, FUR, SPI, Depo Provera
315621,92SIL, AMB, TREPPO, PPI, TOP, SOL, DIG
655124,62NIF, THY, SIL, VYT
606624,82TREP, AMB, TAD, GAB, DIG, SPI, SER
396427,72TREP, BOS, FUR, PPI, SPI
295619,42AMB, TAD, TOP, DAB, FUR, IRO
4438142FSA, AMT, AZE, WAR, DIG, FUR, HCT, PPI, MTZ, CIC, O2, PRM, TREPIV, SIL, SPI, TRAM, TRC, LEV
697528,22AMB, DIL, CLO, LIS, MEF, PIO, FUR, RAN, ROS, SIT, AMT, REP, DAB, MET
455220,32TREPIN, BOS, FUR, WAR
328834,42PRC, BOS, Calcium, IMB, Immodium, LOR, O2, RAN, THY, TREPIV
658427,42DIL, RAL, RAN, FLT, BOS, SPI, Finacea, ASA, CLB, CIT, BME, TREPIN
445419,83SIL, AMB, IMB, EPIV, Calcium, THY, TOR, PPI, DIL, MON, CET, SPI
387028,43BOS, WAR, NOR, ARG, AML, HCT, SD, MOM
488637,23EPIV, BOS, TAD, FUR, PPI, IRO, FA
598631.63AMB, SIL, TREPIN, FUR, ALD, WAR, SIM, IRO, OM3, PPI
Diagnosis*: CTD
5010737.92BOS, SIL, DIL, FUR, WAR, O2
626426.32SIL, MTX, PPI
777227.12BOS, NIF, HCT, THY, PRED, MTX, OM3
587027.32TAD, HCT, WAR, IRO
506026.02AMB, AML, FUR, ALD, DIG, ALL, COL, URS, O2
515423.42BOS, SIL, DIL, THY, PRED
5210438.22BOS, SIL, TREPIN, FUR, BUM, THY, INS, DUL, PRE
578430.92NIF, TREPIV, MTX, PRED, FA, PPI
469136,92SIL, QUE, WAR, TREPIN, PPI, HXC, LOZ
606822,72TREPIN, AMB, SIL, FUR
575220,32AMB, FUR, BUP, CIT, PPI, PEN, ZOL, FEX
576426,02BOS, TAD, FUR, SPI, O2
408226.83BOS, SIL, AML, TREPIV, FUR, ALD, PRED, LOS, CLO, ATE
668331.23BOS, SIL, FUR, ALD, THY, LIS, PRED, AZA, PPI, PAR, O2
285821,82TREPIV, SIL, WAR, HXC, FUR, PRC/OXC, MMF, FLU, THY, PRED, FA, PPI, RAN, ZOL
506325,24PPI, DOM, SIL, AMB, FUR, AML, FA, PRE, LOR
  • *Medications (prostanoids are in bold): ALD=aldactone PO; ALL=allopurinol PO; AMB=ambrisentan PO; AML=amlodipine PO; ALP=alprazolam PO; AMI=amiloride PO; AMT=amitryptilin PO; ARG=l-arginine PO; ASA=acetylsalicylic acid; ATE=atenolol PO; ATO=atorvastatine PO; AZA=azathioprine PO; AZE=azelastine PO; BME=betamethasone PO; BOS=bosentan PO; BUM=bumetanide PO; BUP=bupropion PO; CAV=carvedilol PO; CET=cetirizine PO; CIC=ciclenosid PO; CIT=citalopram PO; CLB=clobetasol topical; CLG=clopidogrel PO; CLO=clonidine PO; COD=codein PO; COL=colchicin PO; DAB=dabigatranexilat PO; DIG=digoxin PO; DIL=diltiazem; DIP=dipyridamole; DOM=domperidone PO; DUL=duloxetine PO; EPIV=epoprostenol IV; ESC=escitalopram PO; FA=folic acid PO; FAM=famotidin PO; FEX=fexofenadine PO; FLT=fluticasone INH; FLU=fluoxetin PO; FSA=fluticasone/salmeterol INH; FUR=furosemide PO; GAB=gabapentin PO; GUA=guifenesin PO; HCT= hydrochlorothiazide PO; HXC=hydroxychloroquine PO; HYD=hydrocodone; ILO=iloprost INH; IMB=imatinib PO; INS=insulin; IRO=iron PO; LEV=levabuterol INH; LIS=lisinopril PO; LOR=loratadin PO; LOS=losartan PO; LOV=lovastatin PO; MED=medodrine; MEF=metformin PO; MET=metoprolol PO; MMF=mycophenolat- mofetil PO; MOM=mometasone PO; MON=montelukast inhal.; MTX=methotrexate PO; MTZ=metronidazole PO; NIF=nifedipine; NOR=norethindrone PO; O2=oxygen by nasal canula; OM3=omega-3-acid ethyl esters PO; OXC=ocycodon PO; PAR=paroxetine PO; PGI=prostanoid; PPI=proton pump inhibitor PO; PRA=pravastatin PO; PRC=paracetamolo PO; PRE=pregabalin; PRED=prednisone PO; PRM=promethazin PO; QUE= quetiapin PO; RAL=raloxifen PO; RAN=ranitidine PO; RIS=risedronate PO; SAL=salmeterol INH; SD=PH study drug; SER=sertraline PO; SIL=sildenafil PO; SIM=simvastatine PO; SIT=sitagliptin PO; SOL=solifenacinsuccinat PO; SPI=spironolactone PO; TAD=tadalafil PO; TEM=temazepam PO; THY=levothyroxine PO; TOP=topiramat PO; TOR=torsemide PO; TRA=trazodone; TRC=triamcinolon PO; TRAM=tramadole; TREP=trepostinil; TREPIV=trepostinil IV; TREPIN=trepostinil inhal.; TREPPO=trepostinil PO ; TREPSC=trepostinil subcutaneously; TRI=triamterene PO; URS=ursodiol PO; VAL=valsartan PO; VEN=venlaxafine PO; VYT=ezetimibe/simvastatin PO; WAR=warfarin PO; ZOL=zolpidem PO †Clinical Classification of Pulmonary Hypertension (World Symposium on PH; Nice 2013) as described in Simonneau G, J Am Coll Cardiol 2013. Parenteral prostacyclin administration (intravenous, inhaled, subcutaneous) in the far right column is indicated in bold letters. The definition of WHO functional class of PAH can be found in Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP Evidence-Based Clinical Practice Guidelines. Introduction. Chest 2004;126:7S–10S. BMI, body mass index; CTD, PAH associated with connective tissue disease (WSPH Nice PH category 1.4.1); DTI, PAH drug and toxin induced (Nice PH category 1.3); HPAH, heritable PAH (Nice PH category 1.2.); IPAH, idiopathic PAH (Nice PH category 1.1); IV, intravenous; PAH, pulmonary arterial hypertension; PO, oral; SC, subcutaneous; SSRI, selective serotonin reuptake inhibitor.